Amikacin/rifampicinAcquired drug resistance: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1730卷 / 1期

关键词：

D O I：

10.1007/s40278-018-54926-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：26 / 26

相关论文

共 50 条

[31] Amikacin/azithromycin/tigecyclineVarious toxicities: 2 case reports
Reactions Weekly, 2023, 1986 (1) : 36 - 36
[32] Amikacin/antithymocyte-globulinAnaphylaxis: 2 case reports
Reactions Weekly, 2017, 1633 (1) : 40 - 40
[33] Amikacin/clofazimineSkin hyperpigmentation and ototoxicity: 2 case reports
Reactions Weekly, 2018, 1727 (1) : 24 - 24
[34] Amikacin/azithromycin/clarithromycinLack of efficacy: 2 case reports
Reactions Weekly, 2023, 1949 (1) : 33 - 33
[35] Amikacin/ciprofloxacin/linezolidLack of efficacy: 2 case reports
Reactions Weekly, 2022, 1913 (1) : 36 - 36
[36] Afatinib/erlotinib/gefitinibAcquired drug resistance: 2 case reports
Reactions Weekly, 2018, 1696 (1) : 18 - 18
[37] Erlotinib/gefitinib/osimertinibAcquired drug resistance: 2 case reports
Reactions Weekly, 2021, 1856 (1) : 201 - 201
[38] Dupilumab/upadacitinibTreatment failure and drug resistance: 2 case reports
Reactions Weekly, 2024, 2026 (1) : 121 - 121
[39] AntineoplasticsAcquired drug resistance and lack of efficacy: 2 case reports
Reactions Weekly, 2022, 1903 (1) : 46 - 46
[40] AntiretroviralsAcquired drug resistance and virological failure: 2 case reports
Reactions Weekly, 2025, 2042 (1) : 55 - 55

← 1 2 3 4 5 →